Home›People›David Feltquate
David Feltquate

David Feltquate

Executive officer at Solstice Oncology.

Executive
Updated Nov 11, 2026·Latest SEC filing Mar 9, 2026·Suggest an edit

About David Feltquate

David Feltquate is an executive officer at Solstice Oncology.

Experience

This experience comes from David Feltquate's profile and from SEC filings. For roles taken from filings, the years are when the filings name David Feltquate in the role, so the role may have started earlier or lasted longer.

Solstice Oncology, Inc. Current
Chief Medical Officer
2026 – Present · Boston, MA
Develops cancer immunotherapy for patients before surgery, beginning with colon cancer.
RA Capital Management
Venture Partner
2025 – 2026
iTeos Therapeutics
Chief Medical Officer
2024 – 2025
Palleon Pharmaceuticals
Chief Medical Officer
2021 – 2024
Novartis
Chair, Precision Medicine Leadership Team
2019 – 2021
BRISTOL-MYERS SQUIBB
Head of Early Clinical Development
2006 – 2019

Key Colleagues at Startups

The people David Feltquate works with at each company, as listed on that company's latest Form D.

Solstice Oncology, Inc. · Form D, Mar 9, 2026
AL
Andrew Levin
Director
Julie Grant
Julie Grant
Director
Emily Minkow
Emily Minkow
Director
Maiken Keson-Brookes
Maiken Keson-Brookes
Executive officer
CL
Caroline Loew
President & CEO, Solstice Oncology, director

Sources

  1. SECSolstice Oncology, Inc. Form D, filed Mar 9, 2026